AAAAAA
Results: 1-25/32
Authors:
LAPORTE JR
DELATORRE FJ
GADGIL DA
CHANDRASEKHAR DV
LASZLO A
RETSAGI G
ALFREDSSON L
MARTINEZ C
KAUFMAN DW
ANDERSON T
KELLY JP
SHAPIRO S
Citation: Jr. Laporte et al., AN EPIDEMIOLOGIC-STUDY OF SEVERE ANAPHYLACTIC AND ANAPHYLACTOID REACTIONS AMONG HOSPITAL PATIENTS - METHODS AND OVERALL RISKS, Epidemiology, 9(2), 1998, pp. 141-146
Authors:
LAPORTE JR
VIDAL X
BALLARIN E
IBANEZ L
Citation: Jr. Laporte et al., POSSIBLE ASSOCIATION BETWEEN OCULAR CHLORAMPHENICOL AND APLASTIC-ANEMIA - THE ABSOLUTE RISK IS VERY-LOW, British journal of clinical pharmacology, 46(2), 1998, pp. 181-184
Authors:
LAPORTE JR
IBANEZ L
BALLARIN E
PEREZ E
VIDAL X
Citation: Jr. Laporte et al., FATAL APLASTIC-ANEMIA ASSOCIATED WITH NIFEDIPINE, Lancet, 352(9128), 1998, pp. 619-620
Authors:
MARTINEZ M
AGUSTI A
ARNAU JM
VIDAL X
LAPORTE JR
Citation: M. Martinez et al., TRENDS OF PRESCRIBING PATTERNS FOR THE SECONDARY PREVENTION OF MYOCARDIAL-INFARCTION OVER A 13-YEAR PERIOD, European Journal of Clinical Pharmacology, 54(3), 1998, pp. 203-208
Authors:
CAPELLA D
LAPORTE JR
VIDAL X
WIHOLM BE
BEGAUD B
LANGMAN MJS
RAWLINS M
Citation: D. Capella et al., EUROPEAN NETWORK FOR THE CASE-POPULATION SURVEILLANCE OF RARE DISEASES (EURONET) - A PROSPECTIVE FEASIBILITY STUDY, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 299-302
Authors:
LAPORTE JR
Citation: Jr. Laporte, ADVERSE DRUG-REACTIONS - THE HIDDEN PART OF THE ICEBERG, Medicina Clinica, 111(3), 1998, pp. 101-102
Authors:
LAPORTE JR
Citation: Jr. Laporte, PLACEBO IN CLINICAL-TRIALS WITH DRUGS, Medicina Clinica, 111(14), 1998, pp. 558-558
Authors:
ARNAU JM
LAPORTE JR
Citation: Jm. Arnau et Jr. Laporte, THERAPEUTIC CONSULTATION - CLINICAL-PHARMACOLOGY, UPDATE OF KNOWLEDGE, AND INDIVIDUALIZATION OF THERAPIES, Medicina Clinica, 111(11), 1998, pp. 417-418
Authors:
MORROS R
FIGUERAS A
CAPELLA D
LAPORTE JR
Citation: R. Morros et al., HYPERSENSITIVITY VASCULITIS RELATED TO ACECLOFENAC, British journal of rheumatology, 36(4), 1997, pp. 503-504
Authors:
LAPORTE JR
DOTRES C
DIOGENE E
PENA JP
REGGI V
MARQUEZ M
Citation: Jr. Laporte et al., CUBA - IMPROVING USE OF MEDICINES, Lancet, 349, 1997, pp. 4-4
Authors:
LLOP R
FERRER A
AGUSTI A
VIDAL X
ARNAU JM
LAPORTE JR
Citation: R. Llop et al., FROM CLINICAL-TRIALS TO CLINICAL-PRACTICE - ORAL ANTICOAGULATION AMONG PATIENTS WITH NONRHEUMATIC, ATRIAL-FIBRILLATION, European Journal of Clinical Pharmacology, 53(1), 1997, pp. 1-5
Authors:
LAPORTE JR
Citation: Jr. Laporte, SELF-DRUG INTAKE - DOES INFORMATION TO US ERS INCREASE AT THE SAME RATE AS CONSUMPTION, Medicina Clinica, 109(20), 1997, pp. 795-796
Authors:
AGUSTI A
MATEU S
MOLINA L
ARNAU JM
VIDAL X
LAPORTE JR
Citation: A. Agusti et al., USE OF THROMBOLYTIC DRUGS IN ACUTE MYOCAR DIAL-INFARCTION IN BARCELONA, SPAIN, Medicina Clinica, 108(5), 1997, pp. 167-170
Authors:
AGUILERA C
ARNAU JM
BOSCH C
CASTEL JM
LAPORTE JR
PAREDES I
VALLANO A
FARRE M
TERAN M
MENOYO E
Citation: C. Aguilera et al., ANALGESICS DURING THE POSTOPERATIVE PERIO D IN ABDOMINAL-SURGERY, Medicina Clinica, 108(4), 1997, pp. 136-140
Authors:
CASTEL JM
LAPORTE JR
REGGI V
Citation: Jm. Castel et al., MULTICENTER STUDY ON SELF-MEDICATION AND SELF-PRESCRIPTION IN 6 LATIN-AMERICAN COUNTRIES, Clinical pharmacology and therapeutics, 61(4), 1997, pp. 488-493
Authors:
MONSO A
RIUDEUBAS J
BARBAL F
LAPORTE JR
ARNAU JM
Citation: A. Monso et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL COMPARING PETHIDINE TO METAMIZOL FOR TREATMENT OF POST-ANESTHETIC SHIVERING, British journal of clinical pharmacology, 42(3), 1996, pp. 307-311
Authors:
LAPORTE JR
IBANEZ L
VENDRELL L
BALLARIN E
Citation: Jr. Laporte et al., BRONCHOSPASM INDUCED BY ROYAL JELLY, Allergy, 51(6), 1996, pp. 440-440
Authors:
LAPORTE JR
VIDAL X
CARNE X
Citation: Jr. Laporte et al., NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN ELDERLY PEOPLE - GASTROINTESTINAL-BLEEDING IS COMMON, BMJ. British medical journal, 311(7001), 1995, pp. 391-392
Authors:
LAPORTE JR
Citation: Jr. Laporte, OVERBURDENED WOMEN, Medicina Clinica, 105(5), 1995, pp. 197-197
Authors:
LAPORTE JR
CAPELLA D
Citation: Jr. Laporte et D. Capella, FULMINANT LIVER-FAILURE BY BENDAZAC, Medicina Clinica, 104(10), 1995, pp. 396-396
Authors:
LLOP R
GOMEZFARRAN F
FIGUERAS A
CAPELLA D
LAPORTE JR
Citation: R. Llop et al., GYNECOMASTIA ASSOCIATED WITH ENALAPRIL AND DIAZEPAM, The Annals of pharmacotherapy, 28(5), 1994, pp. 671-672
Authors:
VALLES JA
VALLANO A
TORRES F
ARNAU JM
LAPORTE JR
Citation: Ja. Valles et al., MULTICENTER HOSPITAL DRUG UTILIZATION STUDY ON THE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM, British journal of clinical pharmacology, 37(3), 1994, pp. 255-259
Authors:
LAPORTE JR
FIGUERAS A
Citation: Jr. Laporte et A. Figueras, PLACEBO-EFFECTS IN PSYCHIATRY, Lancet, 344(8931), 1994, pp. 1206-1209
Authors:
NARVAEZ M
FIGUERAS A
CAPELLA D
LAPORTE JR
Citation: M. Narvaez et al., TINNITUS WITH CALCIUM-CHANNEL BLOCKERS, Lancet, 343(8907), 1994, pp. 1229-1230
Authors:
FIGUERAS A
CAPELLA D
CASTEL JM
LAPORTE JR
Citation: A. Figueras et al., SPONTANEOUS REPORTING OF ADVERSE DRUG-REACTIONS TO NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A REPORT FROM THE SPANISH SYSTEM OF PHARMACOVIGILANCE, INCLUDING AN EARLY ANALYSIS OF TOPICAL-COATED AND ENTERIC-COATED FORMULATIONS, European Journal of Clinical Pharmacology, 47(4), 1994, pp. 297-303